The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Vistagen Therapeutics Inc (NASDAQ: VTGN) was $4.43 for the day, down -9.59% from the previous closing price of $4.9. In other words, the price has decreased by -$9.59 from its previous closing price. On the day, 0.62 million shares were traded. VTGN stock price reached its highest trading level at $4.909 during the session, while it also had its lowest trading level at $4.3918.
Ratios:
Our analysis of VTGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTGN now has a Market Capitalization of 174964848 and an Enterprise Value of 99654848. For the stock, the TTM Price-to-Sale (P/S) ratio is 249.95 while its Price-to-Book (P/B) ratio in mrq is 2.60. Its current Enterprise Value per Revenue stands at 138.218 whereas that against EBITDA is -1.526.
Stock Price History:
The Beta on a monthly basis for VTGN is 0.56, which has changed by 0.8148148 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, VTGN has reached a high of $5.14, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is 9.73%, while the 200-Day Moving Average is calculated to be 49.13%.
Shares Statistics:
VTGN traded an average of 601.44K shares per day over the past three months and 1039240 shares per day over the past ten days. A total of 38.89M shares are outstanding, with a floating share count of 31.98M. Insiders hold about 19.03% of the company’s shares, while institutions hold 44.96% stake in the company. Shares short for VTGN as of 1763078400 were 1517368 with a Short Ratio of 2.52, compared to 1760486400 on 1338753. Therefore, it implies a Short% of Shares Outstanding of 1517368 and a Short% of Float of 5.4899998.
Earnings Estimates
The firm’s stock currently is rated by 4.0 analysts. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$1.43 and -$1.84 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.64, with 4.0 analysts recommending between -$1.6 and -$1.73.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for VTGN’s current fiscal year. The highest revenue estimate was $1.44M, while the lowest revenue estimate was $500k, resulting in an average revenue estimate of $891.8k. In the same quarter a year ago, actual revenue was $486k
